Related Experiment Video

Updated: Apr 23, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

976

Airways microbiota: Hidden Trojan horses in asbestos exposed individuals?

Dimitrios E Magouliotis1, Vasiliki S Tasiopoulou1, Paschalis-Adam Molyvdas1

  • 1Department of Physiology, University of Thessaly Medical School, BIOPOLIS, Larissa 41110, Greece.

Medical Hypotheses
|September 29, 2014
PubMed

Insights

Airway microbiota may facilitate asbestos fiber translocation to the pleura. Certain bacterial toxins could create pores in airway cells, enabling asbestos to reach sub-pleural areas, contributing to malignant pleural mesothelioma development.

Area of Science:

  • Pulmonology
  • Microbiology
  • Oncology

Background:

  • Malignant pleural mesothelioma (MPM) is a rare cancer linked to asbestos exposure.
  • The precise mechanism of asbestos fiber translocation within the pleura remains unclear.

Purpose of the Study:

  • To propose and evaluate a novel hypothesis for asbestos fiber translocation in the pleura.
  • To explore the role of airway microbiota and their secreted toxins in MPM pathogenesis.

Main Methods:

  • Literature review of published data on airway microbiota and toxins.
  • Evaluation of cholesterol-dependent cytolysins (CDCs) as potential mediators of asbestos translocation.
  • Hypothetical modeling of fiber penetration through airway epithelial cells.

Main Results:

  • Certain bacterial proteins may form pores in airway epithelial cells.
  • These pores could allow asbestos fibers to penetrate the lung parenchyma.
  • This mechanism offers a potential pathway for fibers to reach sub-pleural tissues.

Conclusions:

  • Airway microbiota-secreted proteins present a plausible mechanism for asbestos translocation.
  • This pathway may contribute to the development of malignant pleural mesothelioma.
  • Further research is warranted to validate the role of microbiota in asbestos-related lung diseases.

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

8.5K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

944

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
52
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
69
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
28
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
77